Stock Scorecard
Stock Summary for Harrow Inc (HROW) - $40.17 as of 12/3/2025 4:03:22 PM EST
Total Score
6 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HROW
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HROW
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HROW
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HROW
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HROW (45 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Financial Details for HROW
Company Overview |
|
|---|---|
| Ticker | HROW |
| Company Name | Harrow Inc |
| Country | USA |
| Description | Harrow Health, Inc. is a prominent healthcare company based in San Diego, California, focused on the development and commercialization of cutting-edge ophthalmic products. The firm leverages its proprietary formulations and advanced drug delivery technologies to improve patient outcomes for a range of ocular conditions and surgical needs. With a robust portfolio of FDA-approved products, Harrow Health is well-positioned to capitalize on the growing demand for sophisticated eye care solutions in the expanding ophthalmology sector. Driven by a commitment to innovation and improving patient care, the company aspires to be a transformative force in global eye health. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 40.17 |
| Price 4 Years Ago | 8.64 |
| Last Day Price Updated | 12/3/2025 4:03:22 PM EST |
| Last Day Volume | 870,362 |
| Average Daily Volume | 631,885 |
| 52-Week High | 50.72 |
| 52-Week Low | 20.85 |
| Last Price to 52 Week Low | 92.66% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 84.18 |
| Sector PE | 88.06 |
| 5-Year Average PE | -14.98 |
| Free Cash Flow Ratio | 19.99 |
| Industry Free Cash Flow Ratio | 12.19 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 2.72 |
| Total Cash Per Share | 2.01 |
| Book Value Per Share Most Recent Quarter | 1.27 |
| Price to Book Ratio | 32.91 |
| Industry Price to Book Ratio | 10.33 |
| Sector Price to Book Ratio | 33.12 |
| Price to Sales Ratio Twelve Trailing Months | 5.95 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.67 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.97 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 37,037,500 |
| Market Capitalization | 1,487,796,375 |
| Institutional Ownership | 58.13% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -64.00% |
| Annual Earnings Growth | 28.39% |
| Reported EPS 12 Trailing Months | -0.13 |
| Reported EPS Past Year | 0.08 |
| Reported EPS Prior Year | -0.21 |
| Net Income Twelve Trailing Months | -4,988,000 |
| Net Income Past Year | -17,481,000 |
| Net Income Prior Year | -24,411,000 |
| Quarterly Revenue Growth YOY | 45.40% |
| 5-Year Revenue Growth | 31.29% |
| Operating Margin Twelve Trailing Months | 20.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 74,290,000 |
| Total Cash Past Year | 47,247,000 |
| Total Cash Prior Year | 74,085,000 |
| Net Cash Position Most Recent Quarter | -168,584,000 |
| Net Cash Position Past Year | -172,292,000 |
| Long Term Debt Past Year | 219,539,000 |
| Long Term Debt Prior Year | 183,172,000 |
| Total Debt Most Recent Quarter | 242,874,000 |
| Equity to Debt Ratio Past Year | 0.24 |
| Equity to Debt Ratio Most Recent Quarter | 0.16 |
| Total Stockholder Equity Past Year | 69,652,000 |
| Total Stockholder Equity Prior Year | 70,357,000 |
| Total Stockholder Equity Most Recent Quarter | 47,016,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -20,474,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.55 |
| Free Cash Flow Past Year | -60,876,000 |
| Free Cash Flow Prior Year | -148,713,000 |
Options |
|
| Put/Call Ratio | 0.05 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.47 |
| MACD Signal | -0.09 |
| 20-Day Bollinger Lower Band | 31.69 |
| 20-Day Bollinger Middle Band | 39.05 |
| 20-Day Bollinger Upper Band | 46.42 |
| Beta | 0.07 |
| RSI | 56.15 |
| 50-Day SMA | 33.17 |
| 150-Day SMA | 25.40 |
| 200-Day SMA | 21.31 |
System |
|
| Modified | 12/4/2025 1:08:45 AM EST |